Yi Feng has extensive experience in the biopharmaceutical and research sectors, having served in various roles from Writer/Editor at Medjaden to Senior Director of Translational Bioanalytical Oversight at Eli Lilly and Company. They have demonstrated expertise in virology, assay development, and regulatory affairs, holding positions at organizations such as WuXi AppTec and Spark Therapeutics, where they contributed to the success of clinical trials and IND filings. Yi Feng earned a Bachelor's degree from Peking University and a PhD from Vanderbilt University School of Medicine, and they have actively published research while mentoring students throughout their career.
This person is not in any teams
This person is not in any offices